Cargando…

Association between miR-27a rs895819 polymorphism and breast cancer susceptibility: Evidence based on 6118 cases and 7042 controls

BACKGROUND: Polymorphism in miR-27a rs895819 has been associated with breast cancer (BC) risk, but studies have reported inconsistent results. This meta-analysis investigated the possible association between miR-27a rs895819 polymorphism and BC risk. METHODS: PubMed, EMBASE, Google Scholar, and the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yuan, Gui, Yi-Fei, Liao, Wen-Yong, Zhang, Yu-Qin, Zhang, Xiao-Bin, Huang, Yan-Ping, Wu, Feng-Ming, Huang, Zhen, Lu, Yun-Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	5750
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808552/ https://www.ncbi.nlm.nih.gov/pubmed/33466130 http://dx.doi.org/10.1097/MD.0000000000023834

Ejemplares similares

The Associations of Single Nucleotide Polymorphisms in miR196a2, miR-499, and miR-608 With Breast Cancer Susceptibility: A STROBE-Compliant Observational Study
por: Dai, Zhi-Ming, et al.
Publicado: (2016)

Association of two microRNA polymorphisms miR-27 rs895819 and miR-423 rs6505162 with the risk of cancer
por: Zhang, Hong, et al.
Publicado: (2017)

The association of miR‐27a rs895819 polymorphism with colorectal cancer risk in Chinese population
por: Zhang, Shulong, et al.
Publicado: (2020)

Association between CASC16 rs4784227 polymorphism and breast cancer susceptibility: A meta-analysis
por: Liang, Xiong-Shun, et al.
Publicado: (2021)

Pre-miR-27a rs895819A/G Polymorphisms in Cancer: A Meta-Analysis
por: Xu, Qian, et al.
Publicado: (2013)

Pre‐miR‐27a rs895819 polymorphism and risk of diffuse large B‐cell lymphoma
por: Tang, Weiyan, et al.
Publicado: (2019)

The Single-Nucleotide Polymorphism of miR-27a rs895819 and the Expression of miR-27a in Helicobacter pylori-Related Diseases and the Correlation with the Traditional Chinese Medicine Syndrome
por: Zhang, Ling, et al.
Publicado: (2022)

rs11671784 G/A and rs895819 A/G Polymorphisms Inversely Affect Gastric Cancer Susceptibility and miR-27a Expression in a Chinese Population
por: Song, Bo, et al.
Publicado: (2014)

The association between pre-miR-27a rs895819 polymorphism and myocardial infarction risk in a Chinese Han population
por: Cai, Meng-yun, et al.
Publicado: (2018)

The correlation of leukocyte-specific protein 1 (LSP1) rs3817198(T>C) polymorphism with breast cancer: A meta-analysis
por: Chen, Jian, et al.
Publicado: (2022)

MicroRNA Variants miR-27a rs895819 and miR-423 rs6505162, but not miR-124-1 rs531564, are Linked to Endometriosis and its Severity
por: Jaafar, S. O., et al.
Publicado: (2022)

MicroRNAs and Drinking: Association between the Pre-miR-27a rs895819 Polymorphism and Alcohol Consumption in a Mediterranean Population
por: Barragán, Rocío, et al.
Publicado: (2016)

A functional SNP rs895819 on pre-miR-27a is associated with bipolar disorder by targeting NCAM1
por: Yang, Yifeng, et al.
Publicado: (2022)

Correlation between rs13347 polymorphism of CD44 gene and the risk of occurring breast cancer: A protocol for systematic review and meta-analysis
por: Shao, Zilong, et al.
Publicado: (2021)

Genetic Polymorphisms in Long Noncoding RNA H19 Are Associated With Susceptibility to Breast Cancer in Chinese Population
por: Xia, Zongjiang, et al.
Publicado: (2016)

Systematic evaluation of cancer risk associated with rs2292832 in miR-149 and rs895819 in miR-27a: a comprehensive and updated meta-analysis
por: Feng, Yajing, et al.
Publicado: (2016)

Vitamin D Receptor Polymorphism and Breast Cancer Risk: A Meta-Analysis
por: Lu, Demin, et al.
Publicado: (2016)

MiR-27a rs895819 is involved in increased atrophic gastritis risk, improved gastric cancer prognosis and negative interaction with Helicobacter pylori
por: Xu, Qian, et al.
Publicado: (2017)

Prognosis of COVID-19 in patients with breast cancer: A protocol for systematic review and meta-analysis
por: Sheng, Zhijuan, et al.
Publicado: (2020)

Relationship between HLA-DRB1 gene polymorphism and breast cancer: A protocol for systematic review and meta-analysis
por: Liu, Linlin, et al.
Publicado: (2021)

Evaluation of the association between mammographic density and the risk of breast cancer using Quantra software and the BI-RADS classification
por: Wang, Jian Ming, et al.
Publicado: (2020)

Value of Breast Cancer Molecular Subtypes and Ki67 Expression for the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese Population
por: Wang, Jiayu, et al.
Publicado: (2016)

Comprehensive analysis of NT5DC family prognostic and immune significance in breast cancer
por: Jia, Yiwei, et al.
Publicado: (2023)

Impact of WNT1-inducible signaling pathway protein-1 (WISP-1) genetic polymorphisms and clinical aspects of breast cancer
por: Wang, Yan, et al.
Publicado: (2019)

Trastuzumab improves locoregional control in HER2-positive breast cancer patients following adjuvant radiotherapy
por: Cao, Lu, et al.
Publicado: (2016)

Associated of rs895819 with risk of cervical cancer in Chinese women
por: Weng, Yu, et al.
Publicado: (2020)

A single nucleotide polymorphism in codon F31I and V57I of the AURKA gene in invasive ductal breast carcinoma in Middle East
por: Golmohammadi, Rahim, et al.
Publicado: (2017)

Association Between Single Nucleotide Polymorphisms in DNA Polymerase Kappa Gene and Breast Cancer Risk in Chinese Han Population: A STROBE-Compliant Observational Study
por: Dai, Zhi-Jun, et al.
Publicado: (2016)

Efficacy and safety of endocrine monotherapy as first-line treatment for hormone-sensitive advanced breast cancer: A network meta-analysis
por: Zhang, Jingwen, et al.
Publicado: (2017)

Big data-based identification of methylated genes associated with drug resistance and prognosis in ovarian cancer
por: Yan, Bingbing, et al.
Publicado: (2020)

Discordance of immunohistochemical markers between primary and recurrent or metastatic breast cancer: A retrospective analysis of 107 cases
por: Peng, Li, et al.
Publicado: (2020)

Combination of Chinese medicinal formulas and chemotherapy for triple-negative breast cancer strengthens body resistance to eliminate pathogenic factors
por: Zhang, Yiyi, et al.
Publicado: (2022)

Influential factors and prediction model of mammographic density among Chinese women
por: Shang, Mu Yan, et al.
Publicado: (2021)

Surgical management of breast cancer in China: A 15-year single-center retrospective study of 18,502 patients
por: Huang, Nai-si, et al.
Publicado: (2016)

The duration of endocrine therapy and breast cancer patients’ survival: A nationwide population-based cohort study
por: Chang, Chuan-Hsun, et al.
Publicado: (2019)

Endocrine therapies in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative, pretreated, advanced breast cancer: A network meta-analysis
por: Lee, Cho-Hao, et al.
Publicado: (2020)

Efficacy of fulvestrant 500 mg in Chinese postmenopausal women with advanced/recurrent breast cancer and factors associated with prolonged time-to-treatment failure: A retrospective case series
por: Huang, Jian, et al.
Publicado: (2020)

Randomized controlled trial of late-course concurrent versus sequential chemoradiotherapy after mastectomy and axillary surgery in locally advanced breast cancer
por: Lu, Ying, et al.
Publicado: (2017)

Rethinking on the management strategy of malignant phyllodes tumor of the breast: An analysis based on the SEER database
por: Chen, Chang, et al.
Publicado: (2023)

Refusal of cancer-directed surgery in male breast cancer
por: Wang, Shipei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7r928u9b633pls3n5hq2ptchr6